Clinical Trial Supplies Market, By Phases (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Interventional Trails, Observational Trials, and Expanded Access Trials), By Application (Oncology, CNS, Cardiovascular, Infectious Disease, Metabolic Disorders, and Others), By End-user (Contract Research Organizations, Pharmaceutical & BioStudy Design Companies, Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2025

Report Code: PMI422220 | Publish Date: August 2023 | No. of Pages: 168

Global Clinical Trial Supplies Market Overview

Clinical trial is a research study for testing medical drugs or equipment conducted on individuals who volunteered in order to determine treatment for certain disorders or diseases. Clinical trials are performed in order to detect, diagnose, and prevent several types of diseases. Every clinical trials has certain action plans and protocols to execute the testing procedure. It helps to produce data regarding efficiency, effectiveness, and safety of medical treatment and drugs on animals and humans.Clinical Trial Supplies Market accounted for US$ 1.7 billion in 2020 and is estimated to be US$ 2.5 billion by 2025 and is anticipated to register a CAGR of 7.8%.

Global Clinical Trial Supplies Market Dynamics

 

Increasing investment for R&D activities for development of effective medicines

The CROs and biopharmaceutical companies are becoming aware about the importance of logistics and material supply with end-to-end solution in the clinical trials. Rising number of life sciences research in various countries and rising government funding for the development of new drugs are likely to drive the clinical trial supplies market globally. New competitors are focusing on new technologies and launch of new products in the market. Moreover, robust growth in emerging economies provides lucrative growth opportunity to the market stakeholders.

Increasing prevalence of chronic diseases

The global clinical trials supplies market is observing high growth owing to rising prevalence of chronic diseases such as cancer, HIV, and epilepsy. Furthermore, growing prevalence’s of neurological diseases such as Alzheimer’s, Parkinson’s, tumor, epilepsy, depression, along with increasing generic population are also factors projected to boost the target market growth in the coming years. Moreover, rising clinical trials for finding permanent and effective solutions to slowdown or cure and prevent spread of diseases and aging diseases is a factor driving growth of the global market.

High cost of clinical trials

The rules and restrictions regarding conducting clinical trials on individuals is anticipated to limit growth of the target market. Additionally, high cost of clinical trials and its cost differ from each phase of the test, thus hampering growth of the global clinical trial supplies market.

Global Clinical Trial Supplies Market Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The global clinical trial supplies market is segmented based on phases, study design, application, end-user, and region.

On the basis of phases, the global clinical trial supplies market is segmented into Phase I, Phase II, Phase III, and Phase IV. Based on study design, the target market is segmented into interventional trails, observational trials, and expanded access trials. On the basis of application, the target market is classified into oncology, CNS, cardiovascular, infectious disease, metabolic disorders, and others. Based on end-user, the target market is classified into contract research organizations, pharmaceutical & biostudy design companies, research institutes, and others.

Regional Insights:

On region the global clinical trial supplies market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the chief regional market for clinical trial supplies, followed by Europe. This is mainly attributed owing to the presence of well-established biopharmaceutical companies and CROs. In addition, increasing R&D expenditure by pharmaceutical companies in the region. Asia Pacific is projected to register the fastest growth due to easy access to patient, its diverse population, and less translation cost. Latin America and MEA are also anticipated to register significant growth due to growth in number of clinical trials conducted in this region. 

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2025

Market representation

Revenue in USD Million & CAGR from 2020 – 2025

Market Segmentation

By Phases- Phase I, Phase II, Phase III, and Phase IV

By Study Design– Interventional Trails, Observational Trials, and Expanded Access Trials

By Application– Oncology, CNS, Cardiovascular, Infectious Disease, Metabolic Disorders, and Others

By End-user – Contract Research Organizations, Pharmaceutical & BioStudy Design Companies, Research Institutes, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2025. For the purpose of this study, has segmented the global clinical trial supplies market report based on phases, study design, application, end-user, and region.

Global Clinical Trial Supplies Market, By Phases:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Clinical Trial Supplies Market, By Study Design:

  • Interventional Trails
  • Observational Trials
  • Expanded Access Trials

Global Clinical Trial Supplies Market, By Application:

  • Oncology
  • CNS
  • Cardiovascular
  • Infectious Disease
  • Metabolic Disorders
  • Others

Global Clinical Trial Supplies Market, By End-user:

  • Contract Research Organizations
  • Pharmaceutical & BioStudy Design Companies
  • Research Institutes
  • Others

Global Clinical Trial Supplies Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Clinical Trial Supplies Market Key Players

The key players operating the global clinical trial supplies market includes PAREXEL International Corporation, KLIFO A/S, Almac Group Ltd., Patheon Inc., Biocair International Ltd., Movianto GmbH, Sharp Packaging Services, PCI Services, Thermo Fischer Scientific, and Catalent Pharma Solutions. The companies operating in the target market are focusing on the strategic acquisition in order to gain competitive edge in the global market. For instance, in February 2020, PCI Pharma Services (PCI), a prominent pharmaceutical and biopharmaceutical global supply chain solutions provider, declared the acquisition of Bellwyck Pharma Services. The aim of this acquisition was to expand global clinical trial services into Canada and Continental Europe.

Global Clinical Trial Supplies Market Company Profile

  • PAREXEL International Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • KLIFO A/S
  • Almac Group Ltd.
  • Patheon Inc.
  • Biocair International Ltd.
  • Movianto GmbH
  • Sharp Packaging Services
  • PCI Services
  • Thermo Fischer Scientific
  • Catalent Pharma Solutions

 “*” marked represents similar segmentation in other categories in the respective section

Global Clinical Trial Supplies Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Clinical Trial Supplies Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Phase
      • Market Snippet, By Study Design
      • Market Snippet, By Application
      • Market Snippet, By End-user
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Clinical Trial Supplies Market, By Phase, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Phase I
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase II
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase III
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase IV
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Clinical Trial Supplies Market, By Study Design, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Interventional Trails
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Observational Trials
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Expanded Access Trials
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Clinical Trial Supplies Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • CNS
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Metabolic Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Clinical Trial Supplies Market, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Contract Research Organizations
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmaceutical & BioStudy Design Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Research Institutes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Clinical Trial Supplies Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Study Design, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Study Design, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Study Design, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Study Design, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size  and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Study Design, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
      • PAREXEL International Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • KLIFO A/S
      • Almac Group Ltd.
      • Patheon Inc.
      • Biocair International Ltd.
      • Movianto GmbH
      • Sharp Packaging Services
      • PCI Services
      • Thermo Fischer Scientific
      • Catalent Pharma Solutions
  12. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global clinical trial supplies market is segmented based on phases, study design, application, end-user, and region.

Rising number of life sciences research in various countries and rising government funding for the development of new drugs are likely to drive the clinical trial supplies market globally.

North America is the chief regional market for clinical trial supplies, followed by Europe. This is mainly attributed owing to the presence of well-established biopharmaceutical companies and CROs.

The key players operating the global clinical trial supplies market includes PAREXEL International Corporation, KLIFO A/S, Almac Group Ltd., Patheon Inc., Biocair International Ltd., Movianto GmbH, Sharp Packaging Services, PCI Services, Thermo Fischer Scientific, and Catalent Pharma Solutions.